Technical Analysis for GRTS - Gritstone Oncology, Inc.

Grade Last Price % Change Price Change
grade F 11.99 -0.75% -0.09
GRTS closed down 0.75 percent on Thursday, February 21, 2019, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical GRTS trend table...

Date Alert Name Type % Chg
Feb 21 1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Feb 21 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Feb 21 Narrow Range Bar Range Contraction 0.00%
Feb 21 NR7 Range Contraction 0.00%
Feb 21 Earnings Movers Other 0.00%
Feb 20 1,2,3 Retracement Bearish Bearish Swing Setup -0.75%
Feb 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.75%
Feb 20 Narrow Range Bar Range Contraction -0.75%
Feb 20 Earnings Movers Other -0.75%
Feb 20 Up 3 Days in a Row Strength -0.75%

Older signals for GRTS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars—first, a proprietary machine learning-based platform, Gritstone EDGE™, which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient’s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients’ TSNA to drive the patient’s immune system to attack and destroy tumors.
Medicine Cancer Medical Specialties Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Machine Learning Tumors Active Immunotherapy
Is GRTS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.9
52 Week Low 10.89
Average Volume 163,121
200-Day Moving Average 0.0
50-Day Moving Average 15.8878
20-Day Moving Average 12.8145
10-Day Moving Average 12.229
Average True Range 1.2809
ADX 30.36
+DI 11.9315
-DI 24.0828
Chandelier Exit (Long, 3 ATRs ) 12.1973
Chandelier Exit (Short, 3 ATRs ) 14.7327
Upper Bollinger Band 14.4414
Lower Bollinger Band 11.1876
Percent B (%b) 0.25
BandWidth 25.391549
MACD Line -1.1937
MACD Signal Line -1.2942
MACD Histogram 0.1005
Fundamentals Value
Market Cap 152.93 Thousand
Num Shares 12.8 Thousand
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.85
Resistance 3 (R3) 12.88 12.62 12.70
Resistance 2 (R2) 12.62 12.41 12.61 12.65
Resistance 1 (R1) 12.31 12.27 12.18 12.28 12.61
Pivot Point 12.05 12.05 11.99 12.04 12.05
Support 1 (S1) 11.74 11.84 11.61 11.71 11.37
Support 2 (S2) 11.48 11.70 11.47 11.33
Support 3 (S3) 11.17 11.48 11.28
Support 4 (S4) 11.14